Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 5288508)

Published in Blood on December 01, 1971

Authors

G P Canellos, V T DeVita, J Whang-Peng, P P Carbone

Articles by these authors

Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43

Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16

Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol (1989) 5.44

Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer (1977) 4.95

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (1988) 4.26

Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists. J Clin Oncol (1991) 4.22

Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proc Natl Acad Sci U S A (1969) 3.72

Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer (1993) 3.69

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90

Dose: a critical factor in cancer chemotherapy. Am J Med (1980) 2.82

PIK3CA as an oncogene in cervical cancer. Oncogene (2000) 2.75

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res (1987) 2.67

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep (1978) 2.42

Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38

Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc Natl Acad Sci U S A (1988) 2.26

Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol (1968) 2.23

Chromosome translocation in peripheral neuroepithelioma. N Engl J Med (1984) 2.22

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol (2007) 2.17

Cancer of the breast: the past decade (first of two parts). N Engl J Med (1980) 2.14

Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13

NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med (1984) 2.10

Clinical pharmacology of cyclophosphamide. Cancer Res (1973) 2.08

Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet (1986) 2.04

Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol (1985) 2.02

Selection bias in trials of transplantation for metastatic breast cancer: have we picked the apple before it was ripe? J Clin Oncol (1997) 2.02

Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science (1982) 2.02

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst (1990) 1.97

Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94

A computer data base for information on cancer treatment. N Engl J Med (1987) 1.92

Second malignancies complicating Hodgkin's disease in remission. Lancet (1975) 1.90

Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88

Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci U S A (1988) 1.86

Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med (1973) 1.83

Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol (1994) 1.79

Pseudohyperkalemia due to release of potassium from white blood cells during clotting. N Engl J Med (1966) 1.73

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71

Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am (2006) 1.70

T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol (1992) 1.69

Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer (1975) 1.66

Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A (1985) 1.66

Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med (1971) 1.65

American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med (1975) 1.65

Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res (1966) 1.62

A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet (1982) 1.61

Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med (1966) 1.58

Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol (1986) 1.55

Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol (1984) 1.55

The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture. Cancer (1981) 1.52

Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med (1978) 1.52

The cellular biology of the Reed-Sternberg cell. Blood (1994) 1.50

Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) (1987) 1.50

Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet (1975) 1.49

Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med (1972) 1.49

Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res (1987) 1.49

Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A (1984) 1.46

A decade of combination chemotherapy of advanced Hodgkin's disease. Cancer (1972) 1.46

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol (1983) 1.45

Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med (1972) 1.44

The use of drugs in combination for the treatment of cancer: rationale and results. N Engl J Med (1973) 1.43

A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Inst (1976) 1.42

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42

Who should pay for clinical research? J Clin Oncol (1990) 1.41

Hypercalcemia in malignant lymphoma and leukemia. Ann N Y Acad Sci (1974) 1.40

Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. N Engl J Med (1972) 1.40

Report of the Committee on Hodgkin's Disease Staging Procedures. Cancer Res (1971) 1.38

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37

Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA (1966) 1.34

Cancer treatment and age: patient perspectives. J Natl Cancer Inst (1993) 1.34

Osteonecrosis of the femoral head in patients with lymphoma treated with intermittent combination chemotherapy (including corticosteroids). Cancer (1975) 1.33

Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33

Philadelphia-chromosome-positive preleukaemic state. Lancet (1972) 1.33

The kinetics of 67gallium incorporation into inflammatory lesions: experimental and clinical studies. J Lab Clin Med (1974) 1.33

Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med (1976) 1.33

Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A. J Natl Cancer Inst (1972) 1.32

Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. N Engl J Med (1983) 1.32

Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer (1982) 1.32

Infectious mononucleosis: continuous suspension culture of peripheral blood leucocytes. Nature (1968) 1.31

Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. N Engl J Med (1978) 1.30

Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29